Novedades

Novedades y Eventos

Chris Smith Named Next Chief Executive Officer of Ortho Clinical Diagnostics

Aug 27, 2019

Ortho's board of directors has appointed Chris Smith as CEO effective Sept. 9, 2019. He will succeed Robert Yates, who is stepping down as CEO but will continue to serve as Ortho’s non-executive chairman as a member of the board of directors.

Ensayo de Ortho VITROS® Troponina I de Alta Sensibilidad para el Diagnóstico de Infarto Agudo al Miocardio Disponible Ahora en Países de la UE tras obtener la Aprobación CE Mark

Apr 16, 2019

Este ensayo de última generación ayuda en el diagnóstico de infarto agudo al miocardio con mayor rapidez y exactitud y está habilitado en el analizador más nuevo de la compañía, el Sistema Integrado VITROS® XT 7600.

VITROS® XT MicroSlide de Ortho Clinical Diagnostics obtiene la aprobación CE Mark: Primera capacidad de múltiples ensayos que se añade a la tecnología patentada MicroSlide

Mar 13, 2019

El VITROS® XT MicroSlide usa la tecnología óptica de QUIMICA DIGITAL™, la cual recoge mucha más información que antes para cada ensayo permitiendo mejorar el rendimiento, ahorrar tiempo y espacio en el laboratorio y aumentar la productividad con menos necesidad de muestra del paciente para los ensayos.

Robert Yates Named Next Chairman and CEO of Ortho Clinical Diagnostics

Jan 28, 2019

Ortho has appointed Robert Yates as chairman and chief executive officer effective February 12, 2019. Robert Yates will succeed Dr. Martin Madaus, who is retiring after serving as chairman and CEO of Ortho since June 2014.

El Sistema Integrado VITROS® XT 7600 de Ortho Clinical Diagnostics Obtiene la Aprobación CE Mark, Brindando un nuevo enfoque Innovador para la Gestión de Laboratorios Clínicos

Jul 24, 2018

Ortho Clinical Diagnostics anunció hoy la obtención de la aprobación CE Mark para el Sistema Integrado VITROS® XT 7600 de Ortho. Productos no disponibles para la venta en todos los países, favor confirme con su representante de ventas de Ortho

 

China Food and Drug Administration Approves ORTHO VISION® Platform for Transfusion Medicine Labs

Oct 26, 2017

Immunohematology System from Ortho Clinical Diagnostics Now Commercially Available in China

Diabetic Ketoacidosis Assay Collaboration Between Ortho Clinical Diagnostics and EKF Diagnostics

Oct 11, 2017

EKF’s Beta-Hydroxybutyrate LiquiColor® Assay for detection of predominant ketone body Now Available on Ortho’s VITROS® 4600 and VITROS® 5600 

Ortho Clinical Diagnostics to Present Data on Automation in Immunohematology and Demonstrate Its Entire Transfusion Medicine Portfolio at the 2017 AABB Annual Meeting

Oct 2, 2017

Industry Workshop to Address Clinical Outcomes of Titration Studies Using ID-MTS™ Gel Test Method 

FDA Licenses ORTHO™ Sera designed for Extended Phenotype Testing for Use with Ortho ID-MTS™ Gel Card Technology

Sep 26, 2017

“Ortho Sera helps increase confidence in the lab and allow staff to focus on improving lab efficiency,” says Robert Yates, chief operating officer at Ortho.

New NephroCheck® Test Outcomes Data Show Significant Reduction in Kidney Injury, Hospital Stay

Sep 25, 2017

RANDOMIZED CONTROL TRIAL REPORTS 66% REDUCTION IN MODERATE TO SEVERE AKI; 5-DAY REDUCTION IN TOTAL HOSPITAL STAY

“As analyzers evolve, so does transfusion medicine,” an MLO article by Ortho’s Fernando Chaves, MD.

Sep 21, 2017

Learn more about automation and the recent flowering of innovation in blood banking.

Ortho Receives Prestigious ‘Services Excellence’ Award in India

Sep 20, 2017

Recognition is the latest in a string of No. 1 ratings and rankings for holistic Ortho Care™ Support Program.

FDA Approves Two Ortho Clinical Diagnostics Specialty Hepatitis B Assays

Sep 14, 2017

Approval exemplifies Ortho’s commitment to expand menu while streamlining lab operations

Martin Madaus Discusses Ortho's Growth Story on CNBC’s Squawk Box

Aug 10, 2017

How to Manage a Large, Complex Corporate Carve-Out Well: Ortho CEO Dr. Martin Madaus on ​CNBC's Squawk Box

Ortho Clinical Diagnostics Announces Global Agreement to Make B·R·A·H·M·S PCT Assay Available to Ortho Customers

Jul 31, 2017

Assay plays key role in aiding clinicians in the assessment and treatment of sepsis and septic shock

Ortho Clinical Diagnostics to Present 10 Scientific Posters, Seven Products at AACC

Jul 26, 2017

Activities at the annual meeting of American Association for Clinical Chemistry will demonstrate Ortho’s focus on immunodiagnostics and acute kidney injury

Ortho Clinical Diagnostics to Present Data on Early Detection Of Acute Kidney Injury Risk, Immunoassay Development at EUROMEDLAB Athens 2017

Jun 12, 2017

Sponsored educational sessions and product demonstrations at IFCC’s EUROMEDLAB Athens conference for lab professionals .

Ortho Clinical Diagnostics VITROS® NephroCheck® Test for Prediction of Acute Kidney Injury Cleared, Available in Europe

Jun 6, 2017

AKI, the sudden loss of kidney function, can develop without warning and potentially lead to kidney failure and death. Known as a silent killer, AKI is as common and twice as deadly as a heart attack. .

Ortho Chairman and CEO Martin Madaus on Innovation Within the In Vitro Diagnostics Industry: It’s a Decathlon.

May 16, 2017

It’s not a sprint, it’s a decathlon. Ortho Chairman and CEO Martin Madaus on innovation within the in vitro diagnostics industry.

Ortho Clinical Diagnostics Announces Expansion Of Global Agreement With Astute Medical for NephroCheck Test

Mar 13, 2017

Agreement gives Ortho expanded distribution rights in Europe for the NephroCheck Test on the ASTUTE140 platform

Ortho Clinical Diagnostics Awarded Top Honor for Global Excellence in Customer Service

Feb 27, 2017

Ortho Care™ Support Program Recognized As Best-in-Class Service and Support for Hospitals, Hospital Networks, Blood Banks & Labs

Ortho Clinical Diagnostics Submits VITROS® Immunodiagnostic Products HIV Combo Assay to FDA for Review; Applies to Expand Use of Specialty Hepatitis B Assays

Feb 23, 2017

Latest submissions exemplify Ortho’s commitment to expand menu while streamlining lab operations

Ortho Clinical Diagnostics Recognized with Two Global Business Excellence Awards

Feb 2, 2017

ORTHO VISION® Analyzer Wins International Awards for ‘Outstanding Innovation’ and ‘Outstanding Product/Service’ . 

Ortho Clinical Diagnostics Celebrates 1,000 Installations of the ORTHO VISION® Platform Worldwide

Jan 24, 2017

This accomplishment is recognition of the ORTHO VISION® platform’s value to customers, and represents faster growth than Ortho’s previous products in this space.

GenomeWeb 360Dx Highlights CE Mark Approval of ORTHO CONNECT V2.0 Middleware Solution

Jan 12, 2017

ORTHO CONNECT is a comprehensive, integrated, customizable intermediary software that streamlines laboratory operations, allowing lab professionals to manage multiple instruments from a single console

Ortho Clinical Diagnostics Receives CE Mark Approval for ORTHO CONNECT™ V2.0 Middleware Solution

Jan 11, 2017

ORTHO CONNECT™ V2.0 is now commercially available in Europe and other countries accepting CE Mark.

FDA Clears VITROS® Automation Solutions from Ortho Clinical Diagnostics

Oct 28, 2016

Open, flexible and scalable platform empowers laboratory clinicians to take total facility control

 

FDA Clears ORTHO VISION® Max Analyzer for High-Volume Transfusion Medicine Labs

Oct 22, 2016

New Immunohematology System from Ortho Clinical Diagnostics Expands ORTHO VISION® Platform; Now Commercially Available in the United States

Ortho Clinical Diagnostics to Present Data on Automation in Immunohematology, Three Products at 2016 AABB Annual Meeting

Oct 19, 2016

Customer event will feature analysis of mass transfusion protocol implementation in the wake of Orlando attack

Ortho Clinical Diagnostics Announces Ortho Care

Aug 2, 2016

Best-in-Class Service and Support Program for Hospitals, Hospital Networks, Blood Banks and Labs

Ortho Clinical Diagnostics to Present Seven Scientific Posters, Six Products at AACC

Jul 25, 2016

Ortho will present seven scientific posters on its assays and display six products at its booth at the 2016 AACC annual meeting.

Ortho Clinical Diagnostics Receives Coveted #1 Ranking for Service Performance

Jul 19, 2016

Ortho Clinical Diagnostics today announced that it was ranked higher than any other company for overall service performance by an OEM in the in vitro diagnostics industry.

ORTHO VISION® Analyzer Named Innovation Celebration Award Winner at Premier’s Annual Meeting

Jun 23, 2016

Ortho Clinical Diagnostics today announced that its ORTHO VISION® Analyzer has been recognized with a 2016 Innovation Award by members of Premier, Inc.

Ortho Clinical Diagnostics Receives CE Mark Approval For VITROS® Immunodiagnostic HIV Combo Test

Jun 21, 2016

New Test Expands Infectious Disease Assay Portfolio; Will Become Commercially Available in Europe and other countries that accept CE Mark in June

Beckman Coulter and Ortho Clinical Diagnostics Announce Strategic Relationship to Deliver Infectious Disease Testing Menu to Very High-Volume Labs

Jun 8, 2016

Beckman Coulter Diagnostics to Place Ortho’s VITROS® 3600 Systems in Very High-Volume Labs

Ortho Clinical Diagnostics and Beckman Coulter Strategic Relationship Highlighted in CAP TODAY

Jun 8, 2016

Beckman Coulter Diagnostics to Place Ortho’s VITROS® 3600 Systems in Very High-Volume Labs

Ortho Clinical Diagnostics Announces Availability of ORTHO™ Sera Extended Phenotype Testing on ORTHO VISION® Analyzer for BioVue® Cassettes

Apr 28, 2016

Ortho Clinical Diagnostics today announced that ORTHO™ Sera, a fully automated solution for extended antigen phenotyping, is now available on the ORTHO VISION® Analyzer.

Ortho’s Alex Socarrás is Featured in an Exclusive Radio Interview with El Microscopio

Oct 19, 2016

Alex Socarrás discusses our strategy, new products, our customer focus and trends in the clinical laboratory space in Latin America and worldwide.

GenomeWeb’s 360Dx Feature Story Covers Ortho’s Momentum, Growth

Dec 14, 2016

Ortho’s growth and momentum were covered in the first edition of the new diagnostics-focused publication, 360Dx.

CAP Today Highlights FDA Clearance of ORTHO VISION® Max Analyzer

Nov 4, 2016

A Recent Video on Customer Experience of Ortho Clinical Diagnostics’ Lab Data Management Solution at Marion General Hospital

Ortho Colleagues Blog about Workshops on Mass Transfusion Protocol and Reducing the Risk of Alloimmunization at 2016 AABB Annual Meeting

Oct 27, 2016

"Two Ortho colleagues recently guest-blogged for AABB about workshops on mass transfusion protocol in the wake of tragic events, and reducing the risk of alloimmunization during blood transfusion.

Ortho Exec Featured in Industry Publication

Sep 26, 2016

Heidi Casaletto, Ortho’s VP of Transfusion Medicine, was featured in the recent article, "Building a Safer Blood Supply,” in CLP Magazine.

Marion General Hospital Addresses Growing Pressures with Lab Data Management from Ortho Clinical Diagnostics

Sep 6, 2016

A Recent Video on Customer Experience of Ortho Clinical Diagnostics’ Lab Data Management Solution at Marion General Hospital

Karen Davis-Fleischer, vice president Business Fields at Ortho, was featured in a recent article in Clinical Lab Products

Jul 13, 2016

Karen Davis-Fleischer, VP Business Fields at Ortho, was featured in a recent article in Clinical Lab Products.

Ortho Chairman and CEO Martin Madaus Featured in FierceMedicalDevices

Apr 25, 2016

Ortho’s Chairman and CEO speaks about the Company’s progress as an independent company in this Q&A interview with FierceMedicalDevices

Ortho Chairman and CEO Martin Madaus Featured in Medical Laboratory Observer

Dec 1, 2015

Ortho's Chairman and CEO speaks about the Company's pioneering spirit and how it is driving forward as a global partner for clinical laboratories and transfusion medicine.

Ortho Clinical Diagnostics Featured in The Kansan

Nov 6, 2015

Newton Medical Center is the first hospital in the U.S. to order new transfusion medicine analyzer.

Ortho Clinical Diagnostics’ Executive Leader, Jennifer Paine, Recognized by The Regulatory Affairs Professionals Society as a 2015 Top 10 Honoree

Oct 21, 2015

Jennifer Paine, executive vice president of worldwide quality, Regulatory & Compliance, has been recognized by the Regulatory Affairs Professionals Society as a 2015 Top 10 Honoree.

Ortho Clinical Diagnostics Featured in Clinical Laboratory International

Oct 1, 2015

Ortho Clinical Diagnostics researchers present data on pipeline of assays.

Terre Haute Regional Hospital Becomes First to Install the ORTHO VISION™ Analyzer

Nov 12, 2015

Ortho Clinical Diagnostics today announced that Terre Haute Regional Hospital is the first U.S. medical center to install the ORTHO VISION™ Analyzer.

Ortho Clinical Diagnostics Receives CE Mark Clearance for ORTHO VISION™ Max Analyzer for High-Volume Transfusion Medicine Labs

Oct 14, 2015

Ortho Clinical Diagnostics' ORTHO VISION™ Max, a fully automated blood analyzer for high-volume transfusion medicine laboratories, receives CE Mark clearance.

Ortho Clinical Diagnostics Receives 510(k) Clearance for ORTHO VISION™ Analyzer, Making it Commercially Available in the United States

Aug 18, 2015

Ortho Clinical Diagnostics receives 510(k) clearance for ORTHO VISIONTM Analyzer, making it commercially available in the United States.

Ortho Clinical Diagnostics Presents Data on Five Assays in Development at American Association for Clinical Chemistry Annual Meeting

Apr 28, 2016

Ortho Clinical Diagnostics presents data on five assays in development at the American Association for Clinical Chemistry's annual meeting.

Ortho Clinical Diagnostics Receives FDA 510(k) Clearance for VITROS® Chemistry Products HbA1c Reagent Kit, an Enhanced Diabetes Testing Assay

Jun 18, 2015

Ortho Clinical Diagnostics receives FDA 510(k) clearance for VITROS® Chemistry Products HbA1c Reagent Kit, an enhanced diabetes testing assay.

Ortho Clinical Diagnostics and Quotient Announce Agreement to Commercialize Innovative Transfusion Medicine Diagnostic Platform, MosaiQ™

Jan 29, 2015

Ortho Clinical Diagnostics and Quotient announce an agreement to commercialize innovative transfusion medicine diagnostic platform MosaiQTM

Ortho Clinical Diagnostics Sponsors AACC Webinar Nov. 19: 'Clinical Application of Recently Approved Biomarkers of Acute Kidney Injury'

Nov 11, 2014

Ortho Clinical Diagnostics sponsors the American Association for Clinical Chemistry webinar: Clinical Application of Recently Approved Biomarkers of Acute Kidney Injury.

Ortho Clinical Diagnostics Receives CE Mark for ORTHO VISION™ Analyzer to take Full Automation Transfusion Medicine Testing to Next Level

Mar 28, 2016

Ortho Clinical Diagnostics receives CE Mark for ORTHO VISION™ Analyzer to take full automation transfusion medicine testing to the next level.

Ortho Clinical Diagnostics Receives CE Mark for VITROS® Chemistry Products HbA1c Reagent Kit, an Enhanced Diabetes Testing Assay

Oct 17, 2014

Ortho Clinical Diagnostics receives CE Mark for VITROS® Chemistry Products HbA1c Reagent Kit, an enhanced diabetes testing assay.

Ortho Clinical Diagnostics Signs Agreement with Astute Medical, Inc. to Commercialize and Develop Innovative Acute Kidney Injury Tests

Jul 28, 2014

Ortho Clinical Diagnostics signs agreement with Astute Medical, Inc. to commercialize and develop innovative acute kidney injury tests.

Ortho Clinical Diagnostics, Inc. Announces Executive Leadership Additions as it Becomes an Independent, Stand Alone Company

Jul 8, 2014

Ortho Clinical Diagnostics announces executive leadership appointments as it becomes an independent, stand alone company.

Terre Haute Regional Hospital Becomes First to Install the ORTHO VISION™ Analyzer

Nov 12, 2015

Ortho Clinical Diagnostics today announced that Terre Haute Regional Hospital is the first U.S. medical center to install the ORTHO VISION™ Analyzer.

Ortho Clinical Diagnostics Featured in The Kansan

Nov 6, 2015

Newton Medical Center is the first hospital in the U.S. to order new transfusion medicine analyzer.

Ortho Clinical Diagnostics’ Executive Leader, Jennifer Paine, Recognized by The Regulatory Affairs Professionals Society as a 2015 Top 10 Honoree

Oct 21, 2015

Jennifer Paine, executive vice president of worldwide quality, Regulatory & Compliance, has been recognized by the Regulatory Affairs Professionals Society as a 2015 Top 10 Honoree.

Ortho Clinical Diagnostics Receives CE Mark Clearance for ORTHO VISION™ Max Analyzer for High-Volume Transfusion Medicine Labs

Oct 14, 2015

Ortho Clinical Diagnostics' ORTHO VISION™ Max, a fully automated blood analyzer for high-volume transfusion medicine laboratories, receives CE Mark clearance.

Ortho Clinical Diagnostics Featured in Clinical Laboratory International

Oct 1, 2015

Ortho Clinical Diagnostics researchers present data on pipeline of assays.

Ortho Clinical Diagnostics Receives 510(k) Clearance for ORTHO VISION™ Analyzer, Making it Commercially Available in the United States

Aug 18, 2015

Ortho Clinical Diagnostics receives 510(k) clearance for ORTHO VISIONTM Analyzer, making it commercially available in the United States.

Ortho Clinical Diagnostics Presents Data on Five Assays in Development at American Association for Clinical Chemistry Annual Meeting

Jul 29, 2015

Ortho Clinical Diagnostics presents data on five assays in development at the American Association for Clinical Chemistry's annual meeting.

Ortho Clinical Diagnostics Receives FDA 510(k) Clearance for VITROS® Chemistry Products HbA1c Reagent Kit, an Enhanced Diabetes Testing Assay

Jun 18, 2015

Ortho Clinical Diagnostics receives FDA 510(k) clearance for VITROS® Chemistry Products HbA1c Reagent Kit, an enhanced diabetes testing assay.

Ortho Clinical Diagnostics and Quotient Announce Agreement to Commercialize Innovative Transfusion Medicine Diagnostic Platform, MosaiQ™

Jan 29, 2015

Ortho Clinical Diagnostics and Quotient announce an agreement to commercialize innovative transfusion medicine diagnostic platform MosaiQTM

Ortho Clinical Diagnostics Sponsors AACC Webinar Nov. 19: 'Clinical Application of Recently Approved Biomarkers of Acute Kidney Injury'

Nov 11, 2014

Ortho Clinical Diagnostics sponsors the American Association for Clinical Chemistry webinar: Clinical Application of Recently Approved Biomarkers of Acute Kidney Injury.

Ortho Clinical Diagnostics Receives CE Mark for ORTHO VISION™ Analyzer to take Full Automation Transfusion Medicine Testing to Next Level

Oct 28, 2014

Ortho Clinical Diagnostics receives CE Mark for ORTHO VISION™ Analyzer to take full automation transfusion medicine testing to the next level.

Ortho Clinical Diagnostics Receives CE Mark for VITROS® Chemistry Products HbA1c Reagent Kit, an Enhanced Diabetes Testing Assay

Oct 17, 2014

Ortho Clinical Diagnostics receives CE Mark for VITROS® Chemistry Products HbA1c Reagent Kit, an enhanced diabetes testing assay.

Ortho Clinical Diagnostics Signs Agreement with Astute Medical, Inc. to Commercialize and Develop Innovative Acute Kidney Injury Tests

Jul 28, 2014

Ortho Clinical Diagnostics signs agreement with Astute Medical, Inc. to commercialize and develop innovative acute kidney injury tests.

Ortho Clinical Diagnostics, Inc. Announces Executive Leadership Additions as it Becomes an Independent, Stand Alone Company

Jul 8, 2014

Ortho Clinical Diagnostics announces executive leadership appointments as it becomes an independent, stand alone company.

Testing_KK_run6_AR-Press Release

Nov 13, 2017

Testing_KK_run6_AR-Press Release

Testing_KK_run7_AR- Ortho in the News

Nov 13, 2017

Testing_KK_run7_AR- Ortho in the News

Test News

Nov 18, 2017
${loading}